How expectations about progress can shape judgment, and why the evidence still has to lead.

Ambition and curiosity have driven most of my development in markets. It kept me studying, testing ideas and refining my approach through very different conditions, and it is a big part of why I built GB Capital around the research I was already doing.

The same drive has a cost when progress takes longer than I expected. A goal that gives useful direction can quietly become a deadline, and every result starts getting measured against it. The opportunity in front of me hasn’t changed. My patience with it has.

The Expectations Behind a Decision

After years of developing a skill, I want to see that work show up in results. The problem starts when an expectation about the pace of improvement begins steering the decisions meant to produce it.

In markets, that changes what looks like an opportunity. A developing setup starts to look actionable because I’m tired of waiting. A quiet stretch feels unproductive because I expected to be doing more. There have been times I acted on a setup before it was ready, simply because waiting felt like falling behind. That has been one of the harder habits for me to change, because I’m someone who likes to make things happen.

So before acting, I ask one question: has the evidence changed, or have my expectations? Both can produce a convincing explanation in the moment. I want to be clear about which one is driving the decision.

The same applies when I review my approach. Sometimes there’s a real weakness to fix. Sometimes I’m just frustrated with how slowly results are coming. A useful review separates the two.

Activity Feels Like Progress

Activity is easy to measure. Another screen, another adjustment or another trade gives me something to point to. Waiting for the right conditions feels less productive, even when it’s exactly what the approach calls for.

Much of my research follows opportunities before they become actionable. A company can be part of an important theme while its stock still needs time to build constructive structure. Relative strength can improve well before there’s a sensible entry. Spotting something early doesn’t mean acting on it now.

How This Shows Up in the Research

That discipline is built into how my research is organized. Names move from On Watch to High Alert to the Buy List only when the evidence improves, not when I’d like them to. Each stage has a reason attached: what put the name there, what would move it forward and what would take it off the list.

For readers, that means the research shows what is developing and what has earned attention, without pretending every interesting idea is ready today. Tracking a name early still has value. It prepares the decision if the evidence improves, and it shows where leadership may be forming before the move is obvious.

I hold changes to my own process to the same standard. A change should fix something I can identify and explain. Adding complexity because it feels like progress only makes the process harder to evaluate.

Turning Impatience Into a Specific Question

“I should be further along” says nothing about what to improve. A specific question does.

In trading, that means checking whether I’m acting on the opportunities I planned to take, whether the evidence supports my decisions and whether a recurring behavior is getting in the way of execution. In research, it means asking whether the explanation is clear and whether the conclusion follows from the evidence.

Those questions also show what’s working. There have been stretches when preparation, selectivity and execution came together. Understanding what drove those stretches gives me something to repeat, not just something to fix.

Pursuing the Goal Without Forcing the Pace

Patience still needs honest evaluation. A recurring issue deserves action. An approach that isn’t producing worthwhile results over a meaningful period deserves scrutiny. What I want to avoid is letting frustration with the timeline decide what I change.

I’m still ambitious about trading, research and what I’m building at GB Capital. Experience has made me more aware of the expectations I bring to each decision. The bigger goal sets the direction. The next decision still gets made on the evidence in front of me.